Vaccines
1 / 8
Exosomes
Nature’s Nanocarriers: The Evolving Role of Exosomes in Targeted Drug Delivery
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-04May 13, 2025
Oncology
From Coley’s Toxins to mRNA: Reflecting on the History of Cancer Vaccines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-03Mar 02, 2025
Personalized
Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare
Ola Tuvesson; Isa Lindgren, Ph.D.
NorthX Biologics
PAO-01-25-CL-09Feb 14, 2025
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01Aug 19, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07Nov 09, 2023
Inhalation Vaccines
The Exciting Potential of Inhalation Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-022-NI-10Nov 15, 2022
Intranasal Vaccines
Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines
Chad Costley, M.D.
BlueWillow Biologics
PAO-04-022-CL-15Apr 28, 2022
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02Apr 13, 2022
GMP
Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur
Intravacc
PR-M03-22-09Mar 22, 2022
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08Mar 21, 2022
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06Mar 15, 2022
Animal Vaccines
World-Class Solutions for Livestock Vaccines
Medgene Labs
PAO-03-22-R250-09Mar 14, 2022
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika
PR-M03-22-01Mar 01, 2022
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18Feb 18, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22Jan 31, 2022
Vaccines
100 Years in Vaccines and Looking Toward the Future
IDT Biologika
PAO-01-22-R250-13Jan 28, 2022
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
IDT Biologika
PR-M01-22-13Jan 20, 2022
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17Nov 08, 2021
Vaccines
IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion
Ashik Pavagadhi
IDT Biologika
PAO-10-21-CL-07-793Oct 15, 2021
Partnership
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
PR-M06-21-024Jun 18, 2021
1 / 8